PAM
BHVN

Panagora Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Panagora Asset Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,802
Closed -$272K – 1554
2022
Q3 		$272K Buy
+1,802
New +$267K ﹤0.01% 1304
2021
Q4 		– Sell
-2,601
Closed -$361K – 1799
2021
Q3 		$361K Sell
2,601
-41
-2% -$5.12K ﹤0.01% 1450
2021
Q2 		$256K Buy
2,642
+505
+24% +$41K ﹤0.01% 1581
2021
Q1 		$146K Sell
2,137
-78,470
-97% -$6.35M ﹤0.01% 1805
2020
Q4 		$6.91M Sell
80,607
-1,200
-1% -$102K 0.04% 362
2020
Q3 		$5.32M Sell
81,807
-22,501
-22% -$1.47M 0.03% 384
2020
Q2 		$7.63M Buy
104,308
+2,568
+3% +$137K 0.05% 302
2020
Q1 		$3.46M Sell
101,740
-208,699
-67% -$9.54M 0.02% 444
2019
Q4 		$16.9M Buy
310,439
+49,908
+19% +$2.47M 0.08% 253
2019
Q3 		$10.9M Buy
260,531
+26,045
+11% +$1.1M 0.05% 312
2019
Q2 		$10.3M Buy
+234,486
New +$13.2M 0.05% 334
2018
Q4 		– Sell
-26,880
Closed -$1.01M – 2658
2018
Q3 		$1.01M Buy
+26,880
New +$989K ﹤0.01% 1125
2018
Q1 		– Sell
-24,548
Closed -$662K – 2486
2017
Q4 		$662K Hold
24,548
– – ﹤0.01% 1284
2017
Q3 		$918K Buy
24,548
+8,248
+51% +$250K ﹤0.01% 1151
2017
Q2 		$408K Buy
+16,300
New +$375K ﹤0.01% 1414

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Panagora Asset Management's BHVN Position: Q4 2022 in Review

Panagora Asset Management sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 1,802 shares — an estimated $272K sold.

Panagora Asset Management first reported a position in BHVN in Q2 2017 and held it in 15 quarters. The position peaked at $16.9M in Q4 2019. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Panagora Asset Management reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Panagora Asset Management sold 1,802 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $272K.
  • Panagora Asset Management first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 15 quarters.
  • Panagora Asset Management's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $16.9M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Panagora Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.